<DOC>
	<DOCNO>NCT00184769</DOCNO>
	<brief_summary>This trial conduct Europe . Objective ( ) : To evaluate effect human growth hormone infant age 1 2 year chronic renal insufficiency ( CRI ) growth retardation despite adequate dietary intake . Trial Design : This open , parallel group clinical trial duration one year , period 50 % patient receive GH treatment 50 % act control group , without treatment . Trial Population : The trial involve total 16 infant age 12±3 24 month suffer chronic renal insufficiency ( Glomerular Filtration Rate le 60 ml/min/1.73 m2 ) , growth failure undergo conservative treatment peritoneal dialysis . Include key inclusion exclusion criterion .</brief_summary>
	<brief_title>Growth Hormone Treatment Infants Aged 1 2 Years With Chronic Renal Insufficiency ( CRI ) Growth Retardation .</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Patients infant sex age 12 ± 3 month chronic renal insufficiency growth retardation . To included trial , patient must meet follow inclusion criterion a. ) c . ) : . ) Male female infant chronological age 12 ± 3 month b . ) Chronic renal insufficiency Glomerular Filtration Rate le 60 ml/min./1.73m2 , accord method use routinely participate center c. ) Growth retardation document start trial , accord follow criterion : Length le 2 SDS chronological age sex linear growth velocity &lt; P50 accord Hernández standard Lubchenko case infant bear prematurely ( &lt; 37 week ) Conservative treatment chronic peritoneal dialysis Euthyroid The parent guardian must give informed consent child 's participation study trial related activity . Trial related activity procedure would perform normal management subject Optimal nutritional management criterion meet Appropriate metabolic control severe hyperparathyroidism , hydroelectrolyte balance , acidbase balance calciumphosphorus balance Any primary endocrinological disorder severe renal osteodystrophy.Other cause , apart CRI , give rise growth retardation.Hydrocephalus . Known suspect allergy trial product relate product . Treatment corticosteroid within last six month . Renal disease due Fanconi syndrome oxalosis ( except dialysis ) . Known suspected malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>